Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yagihashi, S.
Right arrow Articles by Nagai, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yagihashi, S.
Right arrow Articles by Nagai, K.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 41, Issue 1 47-52, Copyright © 1992 by American Diabetes Association


ARTICLES

Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats

S Yagihashi, M Kamijo, M Baba, N Yagihashi and K Nagai
Department of Pathology and Neurology, Hirosaki University School of Medicine, Japan.

Nonenzymatic glycosylation of structural proteins and the formation of advanced glycosylation end products (AGEs) have been involved in the pathogenesis of diabetic complications. We examined the effect of aminoguanidine, a potent inhibitor of AGE formation, on functional and structural abnormalities in peripheral nerve of streptozocin-induced diabetic rats. Diabetic rats were treated with daily injections of 25 mg/kg body wt s.c. aminoguanidine (AG)-sulfate for 16 wk and compared to untreated diabetic rats. AG treatment improved motor nerve conduction velocity in 12- and 16-wk diabetic rats despite no changes in body weight, blood glucose, and HbAIc levels. AG treatment inhibited an accumulation of fluorescent AGE in diabetic nerves, and morphometric analysis of the sural nerve showed a partial effect on myelinated fiber size and axonal atrophy. These findings suggest that AG may have a beneficial effect on diabetic neuropathy and nonenzymatic glycosylation of peripheral nerve proteins.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. Nakae, H. Kamiya, K. Naruse, N. Horio, Y. Ito, R. Mizubayashi, Y. Hamada, E. Nakashima, N. Akiyama, Y. Kobayashi, et al.
Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats.
Diabetes, May 1, 2006; 55(5): 1470 - 1477.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Naruse, Y. Hamada, E. Nakashima, K. Kato, R. Mizubayashi, H. Kamiya, Y. Yuzawa, S. Matsuo, T. Murohara, T. Matsubara, et al.
Therapeutic Neovascularization Using Cord Blood-Derived Endothelial Progenitor Cells for Diabetic Neuropathy
Diabetes, June 1, 2005; 54(6): 1823 - 1828.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. Georg, A. Kautzky-Willer, K. Mahdjoobian, A. Hofer, R. Prager, G. Pacini, and B. H. Ludvik
Influence of Metabolic Control on Splanchnic Glucose Uptake, Insulin Sensitivity, and the Time Required for Glucose Absorption in Patients With Type 1 Diabetes
Diabetes Care, November 1, 2002; 25(11): 2042 - 2047.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
D. R. Sell, J. F. Nelson, and V. M. Monnier
Effect of Chronic Aminoguanidine Treatment on Age-Related Glycation, Glycoxidation, and Collagen Cross-linking in the Fischer 344 Rat
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2001; 56(9): B405 - 411.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C. Yabe-Nishimura
Aldose Reductase in Glucose Toxicity: A Potential Target for the Prevention of Diabetic Complications
Pharmacol. Rev., March 1, 1998; 50(1): 21 - 34.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Wrobel, K. Wrobel, Ma. E. Garay-Sevilla, L. E. Nava, and J. M. Malacara
Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system
Clin. Chem., September 1, 1997; 43(9): 1563 - 1569.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Shoda, S. Miyata, B.-F. Liu, H. Yamada, T. Ohara, K. Suzuki, M. Oimomi, and M. Kasuga
Inhibitory Effects of Tenilsetam on the Maillard Reaction
Endocrinology, May 1, 1997; 138(5): 1886 - 1892.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. M. Cockroft, M. Meistrell III, G. A. Zimmerman, D. Risucci, O. Bloom, A. Cerami, K. J. Tracey, and G. Feuerstein
Cerebroprotective Effects of Aminoguanidine in a Rodent Model of Stroke
Stroke, August 1, 1996; 27(8): 1393 - 1398.
[Abstract] [Full Text]


Home page
NEJMHome page
C. M. Clark and D. A. Lee
Prevention and Treatment of the Complications of Diabetes Mellitus
N. Engl. J. Med., May 4, 1995; 332(18): 1210 - 1217.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Gerhardinger, M. S. Marion, A. Rovner, M. Glomb, and V. M. Monnier
Novel Degradation Pathway of Glycated Amino Acids into Free Fructosamine by a Pseudomonas sp. Soil Strain Extract
J. Biol. Chem., January 6, 1995; 270(1): 218 - 224.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
Z Makita, H Vlassara, E Rayfield, K Cartwright, E Friedman, R Rodby, A Cerami, and R Bucala
Hemoglobin-AGE: a circulating marker of advanced glycosylation
Science, October 23, 1992; 258(5082): 651 - 653.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1992 by the American Diabetes Association.